Abstract:Abstract Background Lung cancer in very young adults in China aged <30 is on the rise and the clinicopathological characteristics of this unique population are incomplete and are yet to be elucidated. Our study aims to explore the characteristics, trends and distinctive features of lung cancer this age group to provide more information that can aid in developing optimal treatment regimens and improve prognosis for this exclusive age group. Method A retrospective review of 141 lung cancer patients admitted at our hospital from August 2011 to October 2021 was performed. The focused age group in our study was 18-30 years old. The data collected included demographics, tumor pathology, gene mutations, and treatment. Overall survival and prognosis were systematically analyzed. Results From a total of 141 of young lung cancer patients, 139 were included in final analysis. The gender distribution in our series favored female(65.5%), and only 7.2% of the study cohort had a history of smoking. Adenocarcinoma was the most common histological type in our study, presenting 93.5% of all patients. The most common stages at diagnosis was stage I(61.2%) and stage IV(30.2%). Genetic testing was performed in only 24.5% (34/139) of the patients. From the 23/34 patients in our study who tested positive for a genetic mutation, 19 (82.3%) were stage IV. The most common gene mutation was Anaplastic Lymphoma kinase(ALK) rearrangement observed in 13/23 (56.5%) gene mutation positive patients. Among stage IV NSCLC, OS was longer in patients who received targeted therapy, compared to the patients not receiving target therapy: 88 months vs 24 months (95% CI: 0.15-1.0, p=0.0282). Conclusion Lung cancer in the young adult population has particular characteristics (Common in female, non-smoker and adenocarcinoma patients). Higher stages of disease were observed in those with a gene mutation (notably ALK rearrangement). Although the sample size was small, the current data suggests a higher mutation rate in the younger population. These findings have fundamental implications for practice and we propose that all patients under 30 diagnosed with lung cancer should undergo genetic testing so they can receive personalized treatment and therefore achieve better outcomes.

Clinicopathological Features And Prognostic Factors Of Young Patients With Surgically Treated Liver Cancer

The clinical features of breast cancer in young patients

Disparities of Age-Based Cancer-Specific Survival Improvement with Various Clinicopathologic Characteristics for Kidney Cancer

Impact Of Age On The Survival Of Patients With Liver Cancer: An Analysis Of 27,255 Patients In The Seer Database

Retrospective Analysis on 682 Cases of Liver Cancer after Surgical Treatment

Clinicopathologic Characteristics and Prognosis for Young Gastric Adenocarcinoma Patients after Curative Resection

Pathological Features and Survival Outcomes of Young Patients with Operable Colon Cancer: Are They Homogeneous?

The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model

Clinical Characteristics and Prognosis of Early-Onset Hepatocellular Carcinoma: A Retrospective Cohort Study Based on Population Data

Clinicopathological characteristic and prognosis analysis of young patients with colorectal cancer

Clinical Significance of Age at Diagnosis among Young Non-Small Cell Lung Cancer Patients under 40 Years Old: a Population-Based Study

Studying the Impact of Young Age on Prognosis and Treatment in Laryngeal Squamous Cell Carcinomas Using the SEER Database

Demographics, Risk Factors and Survival Analysis of Lung Cancer in Young Adults (&lt;30 Years) in China-A Retrospective Cohort Study

Clinical Characteristics and Prognosis of Young Patients with Colorectal Cancer in Eastern China

Characteristics and Prognosis of Primary Liver Cancer in Young Patients in China

Characteristics and Prognostic Analysis of 60 Young Patients with Lung Cancer

Overall Survival of Young Patients with Hepatocellular Carcinoma in Barcelona Clinic Liver Cancer Stage B in a Retrospective Study Based on a Multicenter Cohort

Clinicopathological Features and Prognosis of Patients <45 Years Old with Esophageal Adenocarcinoma Comparing to Other Age Groups.

Stage IV Non-Small Cell Lung Cancer among Young Individuals: Incidence, Presentations, and Survival Outcomes of Conventional Therapies

Better Cancer-Specific Survival in Young Patients with Nonmetastatic Intrahepatic Cholangiocarcinoma: A Retrospective Study of SEER Database.

Surgical outcomes for non‐small cell lung cancer in younger adults: A population‐based study